Bioinformatics and Our Microbiome
ArticlesDrug Discovery and DevelopmentPodcasts

Say Hello to Your Littlest Friends — the Microbiota

How well do you understand your microbiota? Dr. Allyson Byrd of Genentech, the fourth guest on Brilliant Science, is a bioinformatician focusing on parsing all the data our microbiomes have to offer. Read about the value of analyzing microbiota and how Dr. Byrd hopes to leverage the results.
READ MORE →
Brilliant Science Podcast Series
ArticlesDrug Discovery and DevelopmentPodcasts

Podcast: Brilliant Science Podcast Series

The Brilliant Science podcasts will introduce you to some of the amazing science being done around the world. Join us every month to see what you can learn.
READ MORE →
Single-Cell Analysis and the Endless Possibilities
ArticlesDrug Discovery and DevelopmentPodcasts

Finding New Horizons — What Possibilities Exist with Single-Cell Analysis?

Single-cell techniques offer exciting, new ways to understand personalized medicine and research. Developing these techniques at Bio-Rad is Dr. Kelly Kaihara, the third guest on Brilliant Science. Read about what makes single-cell analysis different and Kaihara’s perspective on its potential moving forward.
READ MORE →
Phagocytosis and Phasing Out Disease
ArticlesDrug Discovery and DevelopmentPodcasts

Phagocytosis and Phasing Out Disease

Our immune systems could soon hold the key to rewriting disease and disorder treatments. Studying the inner workings of the immune system’s primary weapon, the macrophage, with the help of CRISPR is Dr. Adam Hoppe at SDSU. Read more about his exciting work and what he hopes to accomplish next.
READ MORE →
NYU Prof Harnesses CRISPR to End Muscular Dystrophy
ArticlesDrug Discovery and DevelopmentPodcasts

NYU Prof Harnesses CRISPR to End Muscular Dystrophy

On the scientific horizon are possibilities of curing genetic disorders and altering disease management — all because of CRISPR. Investigating exciting approaches to reversing the effects of muscular dystrophy with the help of CRISPR is Dr. Chengzu Long at NYU. Read more about his life, his work, and where he sees CRISPR going next.
READ MORE →
Podcast: The Ups and Downs of Biosimilar Development
ArticlesDrug Discovery and DevelopmentPodcasts

Podcast: The Ups and Downs of Biosimilar Development

In this podcast, biosimilar key opinion leader Dr. Paul Rhyne provides an overview of the current state of biosimilars and their global impact. Leveraging his 20+ years of experience in developing biologics, he discusses how cost and patient access play a big role in this new field of research.
READ MORE →
Top Five Podcasts of 2017
ArticlesGeneral InterestPodcasts

Top Five Podcasts of 2017

2017 saw the launch of Bioradiations’ first-ever podcast! Here you can listen to the top five podcasts we published this year, and learn about a variety of topics from CRISPR gene editing to what biomarkers and biosimilars are.
READ MORE →
ArticlesDrug Discovery and DevelopmentGeneral InterestPodcasts

Podcast: The Importance of In Vitro Assays in the Development of Biosimilars

In this podcast, biosimilar expert, Amanda Turner, provides an in-depth explanation of the various in vitro assays used in biosimilar development and the importance of choosing the right assay type and components to achieve success.
READ MORE →
ArticlesCell BiologyPodcasts

Podcast: BrdU in Adult Neurogenesis Research

In this podcast, you will learn about the history of bromodeoxyuridine (BrdU) and how it was established as a popular tool for neurogenesis research. Gain insight into the latest BrdU-related findings and get five practical tips for controlling your BrdU labeling experiments.
READ MORE →
ArticlesDrug Discovery and DevelopmentPodcasts

Podcast: Why Biomarkers Are Important for Clinical Trial Success

In this podcast, learn more about biomarkers and their importance in clinical trials and how data-rich tools are being used to collect and curate the vast amounts of publicly available information about biomarkers.
READ MORE →